443 results
Cases on complications: stable CAD, stents & scaffolds
08 Oct 2021 – From AICT AsiaPCR 2021
Watch this session to discover a selection of cases on stable CAD, stents & scaffolds and learn more about how to cope with complications.
Abstracts: Use of balloons in Bifurcation Lesions
08 Oct 2021 – From AICT AsiaPCR 2021
Watch this session to discover a selection of abstracts on stents, scaffolds and DEB, and learn more about the outcome of balloon-embedded bifurcation stenting with single stent for side branch protection, the differences between biodegradable vs. durable polymer DES with short-term DATP, and more!
Putting evidence in clinical practice of managing high-bleeding risk (HBR) patients
06 Oct 2021 – From AICT-AsiaPCR 2021
In this video, Aaron Wong and Paul Ong share their views on the contribution of various stents to the treatment of HBR patients and the value of durable, biodegradable, non-polymer stents in specific cases. They base their discussion on the results of numerous studies on stents using...
Treating complex coronary lesions: right case right time Prevail™ DCB
01 Oct 2021 – From AICT-AsiaPCR 2021
Thanks to this session, find out more about indications for drug-coated balloons, or, on the contrary, learn when not to use it. And through the analysis of two concrete cases, see how DCB can be an important tool to tackle increasingly complex patients and anatomies, especially...
Telescope guide extension catheter in complex coronary interventions
01 Oct 2021 – From AICT-AsiaPCR 2021
View the complex case of this 70-year-old male patient with hypertension and diabetes who presented with chest pain and NSTEMI, which shows that, when dealing with challenging calcific disease, guide catheter extensions help improve device delivery.
MASTER DAPT trial: dual antiplatelet therapy after coronary stenting in high bleeding risk patients
01 Oct 2021 – From AICT-AsiaPCR 2021
In this session dedicated to the MASTER DAPT study, considered the largest HBR trial to date, learn about the baseline characteristics, clinical presentation, and procedural characteristics of this large trial carried out across 4 continents, before hearing our speakers' interpretation of its 30-days outcomes.
Imaging and robotics in the catheterization laboratory of the future
20 Sep 2021
At a time when the prevention of the health of health care personnel is at the forefront, as well as that of the patient, innovations in imaging are arousing increasing interest. Similarly, the integration of new technologies, and in particular the use of artificial intelligence and...
Author
Author
Author
Author
Author
Author
Delayed compromise of a “super dominant” RCA and Shock
14 Sep 2021
Coronary obstruction is a known procedural complication of aortic valve replacement. However, delayed presentation few months after surgical AVR is a relatively unusual phenomenon. We describe a 75 year old woman with surgical AVR who presented with acute coronary syndrome and severe RV failure few months...
Author
MASTER-DAPT: “the MASTER of high-bleeding risk trials”
28 Aug 2021
Marco Valgimigli (Lugano, Switzerland) presented the results of the MASTER DAPT trial on Saturday, August 28, in a Hot Line session of the ESC Congress 2021. Luis G. Ortega-Paz provides his PICOT & SWOT analysis of this study.
Author
MASTER DAPT: dual antiplatelet therapy after coronary stenting in high bleeding risk patients - interview with Marco Valgimigli
28 Aug 2021
ESC Congress 2021: Discover the interview given by Marco Valgimigli to Luis G. Ortega-Paz for PCRonline about the MASTER-DAPT trial to assess whether one month of dual antiplatelet therapy preserves the net and major adverse cardiovascular events.
Author
Author
